Correction to: Opicapone: A Review in Parkinson’s Disease

被引：0
|
作者：
Lesley J. Scott
机构：
[1] Springer,
来源：
Drugs | 2018年 / 78卷 / 1期
关键词：
D O I：
10.1007/s40265-017-0847-5
中图分类号：
学科分类号：
摘要：
Parkinson’s disease (PD) is the most common chronic, progressive, neurodegenerative disease, with a mean age of onset of 57 years [1, 2].
引用
收藏
页码：153 / 154
页数：1
相关论文
共 50 条
  • [1] Opicapone: A Review in Parkinson's Disease
    Scott, Lesley J.
    [J]. DRUGS, 2016, 76 (13) : 1293 - 1300
  • [2] Opicapone: A Review in Parkinson's Disease
    Scott, Lesley J.
    [J]. CNS DRUGS, 2021, 35 (01) : 121 - 131
  • [3] Opicapone: A Review in Parkinson’s Disease
    Lesley J. Scott
    [J]. CNS Drugs, 2021, 35 : 121 - 131
  • [4] Opicapone: A Review in Parkinson’s Disease
    Lesley J. Scott
    [J]. Drugs, 2016, 76 : 1293 - 1300
  • [5] Opicapone for the treatment of Parkinson's disease: a review
    Feldman, Matthew
    Margolesky, Jason
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (05) : 532 - 543
  • [6] Erratum to: Opicapone: A Review in Parkinson’s Disease
    Lesley J. Scott
    [J]. Drugs, 2016, 76 : 1505 - 1505
  • [7] Correction to: Opicapone in Parkinson’s disease: a profile of its use
    Lesley J. Scott
    [J]. Drugs & Therapy Perspectives, 2018, 34 (1) : 41 - 42
  • [8] Clinical pharmacology review of opicapone for the treatment of Parkinson's disease
    Fabbri, Margherita
    Rosa, Mario M.
    Ferreira, Joaquim J.
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (05) : 349 - 362
  • [9] Opicapone for the treatment of Parkinson's disease
    Rodrigues, Filipe B.
    Ferreira, Joaquim J.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (04) : 445 - 453
  • [10] Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
    Fabbri, Margherita
    Ferreira, Joaquim J.
    Lees, Andrew
    Stocchi, Fabrizio
    Poewe, Werner
    Tolosa, Eduardo
    Rascol, Olivier
    [J]. MOVEMENT DISORDERS, 2018, 33 (10) : 1528 - 1539
12345